Skip to main content
SpringerLink
Log in

Children with profound biotinidase deficiency should be treated with biotin regardless of their residual enzyme activity or genotype

  • Correspondence
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Moslinger D, Stockler-Ipsiroglu S, Scheibenreiter S, Tiefenthaler M, Muhl A, Seidl R, Strobl W, Plecko B, Suormala T, Baumgartner ER (2001) Clinical and neuropsychological outcome in 33 patients with biotinidase deficiency ascertained by nationwide newborn screening and family studies in Austria. Eur J Pediatr 160: 277–282

    Article  CAS  PubMed  Google Scholar 

  2. Wolf B, Grier RE, Allen RJ, Goodman SI, Kien CL, Parker WD, Howell DM, Hurst DL (1983) Phenotypic variation in biotinidase deficiency. J Pediatr 103: 233–237

    Article  CAS  PubMed  Google Scholar 

  3. Wolf B, Norrgard K, Pomponio RJ, Mock DM, Secor McVoy JR, Fleischhauer K, Shapiro S, Blitzer MG, Hymes J (1997) Profound biotinidase deficiency in two asymptomatic adults. Am J Med Genet 73: 5–9

    Article  CAS  PubMed  Google Scholar 

  4. Wolf B, Pomponio RJ, Norrgard KJ, Lott IT, Baumgartner ER, Suormala T, Raemaekers VT, Coskun T, Tokatli A, Ozalp I, Hymes J (1998) Delayed-onset profound biotinidase deficiency. J Pediatr 132: 362–365

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Connecticut Children's Medical Center, Hartford, Connecticut, USA

    Barry Wolf

Authors
  1. Barry Wolf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Barry Wolf.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wolf, B. Children with profound biotinidase deficiency should be treated with biotin regardless of their residual enzyme activity or genotype. Eur J Pediatr 161, 167–168 (2002). https://doi.org/10.1007/s00431-001-0902-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-001-0902-8

Keywords

Search

Navigation